4.5 Article

Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition

期刊

ACS MEDICINAL CHEMISTRY LETTERS
卷 10, 期 4, 页码 601-605

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.8b00589

关键词

Fragment-based approach; anticancer agent; one-pot microwave reaction; JMJD3 inhibitor; melanoma

资金

  1. Associazione Italiana per la Ricerca sul Cancro (AIRC)
  2. Fondazione Cariplo [17099]

向作者/读者索取更多资源

JMJD3 is a member of the KDM6 subfamily and catalyzes the demethylation of lysine 27 on histone H3 (H3K27). This protein was identified as a useful tool in understanding the role of epigenetics in inflammatory conditions and in cancer as well. Guided by a virtual fragment screening approach, we identified the benzoxazole scaffold as a new hit suitable for the development of tighter JMJD3 inhibitors. Compounds were synthesized by a microwave-assisted one-pot reaction under catalyst and solvent-free conditions. Among these, compound 8 presented the highest inhibitory activity (IC50 = 1.22 0.22 /./M) in accordance with molecular modeling calculations. Moreover, 8 induced the cycle arrest in S-phase on A375 melanoma cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders

Martina Pierri, Erica Gazzillo, Maria Giovanna Chini, Maria Grazia Ferraro, Marialuisa Piccolo, Francesco Maione, Carlo Irace, Giuseppe Bifulco, Ines Bruno, Stefania Terracciano, Gianluigi Lauro

Summary: A well-structured in silico workflow is reported for discovering structure-based pharmacophore models against BRD9, accelerating virtual screening and facilitating the identification of novel binders.

BIOORGANIC CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Structural Refinement of 2,4-Thiazolidinedione Derivatives as New Anticancer Agents Able to Modulate the BAG3 Protein

Dafne Ruggiero, Stefania Terracciano, Gianluigi Lauro, Michela Pecoraro, Silvia Franceschelli, Giuseppe Bifulco, Ines Bruno

Summary: The BAG3 protein is involved in multiple cellular pathways and its elevated expression in tumor cells promotes cell survival and apoptosis resistance. It has been identified as a potential target for controlling cancer-related signaling pathways. A synthetic BAG3 modulator, compound 6, has been discovered with significant anti-proliferative effects on cancer cells.

MOLECULES (2022)

Article Chemistry, Organic

6-Methylquinazolin-4(3H)-one Based Compounds as BRD9 Epigenetic Reader Binders: A Rational Combination of in silico Studies and Chemical Synthesis

Ester Colarusso, Erica Gazzillo, Eleonora Boccia, Assunta Giordano, Maria Giovanna Chini, Giuseppe Bifulco, Gianluigi Lauro

Summary: Novel 6-methylquinazolin-4(3H)-one-based compounds were identified and synthesized as binders of the BRD9 epigenetic reader. Molecular docking experiments led to the selection of 16 compounds with good yields and binding potency toward BRD9, with compounds 14, 16, 18, 22, and 26 showing the highest activity.

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation

Erica Gazzillo, Stefania Terracciano, Dafne Ruggiero, Marianna Potenza, Maria Giovanna Chini, Gianluigi Lauro, Katrin Fischer, Robert Klaus Hofstetter, Assunta Giordano, Oliver Werz, Ines Bruno, Giuseppe Bifulco

Summary: The development of new bioactive compounds is a major focus in drug discovery. In order to identify new drug candidates against relevant biological targets, various tools and methodologies are used. In this study, a 3D structure-based pharmacophoric model was employed to re-evaluate a library of compounds, leading to the successful repositioning of certain molecules to a different biological target.

MOLECULES (2022)

Article Chemistry, Medicinal

Identification of 2,4-Dinitro-Biphenyl-Based Compounds as MAPEG Inhibitors

Simone Di Micco, Stefania Terracciano, Martina Pierri, Vincenza Cantone, Stefanie Liening, Stefanie Koenig, Ulrike Garscha, Robert Klaus Hofstetter, Andreas Koeberle, Oliver Werz, Ines Bruno, Giuseppe Bifulco

Summary: By molecular docking and cell-based assays, we discovered that 2,4-dinitro-biphenyl-based compounds can inhibit the activity of leukotriene C-4 synthase and 5-lipoxygenase-activating protein, both important members in the biosynthesis of pro-inflammatory eicosanoids. The compounds also showed inhibitory effects on another related protein, suggesting that the 2,4-dinitro-biphenyl scaffold is a suitable molecular platform for modulating pro-inflammatory mediators in inflammation and cancer treatment.

CHEMMEDCHEM (2022)

Article Chemistry, Medicinal

Extensive Molecular Dynamics Simulations Disclosed the Stability of mPGES-1 Enzyme and the Structural Role of Glutathione (GSH) Cofactor

Simone Di Micco, Gianluigi Lauro, Giuseppe Bifulco

Summary: This study used molecular dynamics simulations to investigate the structure and function of microsomal prostaglandin E-2 synthase-1 (mPGES-1) protein systems. The results revealed the structural role of glutathione (GSH) in the enzyme's chemical architecture and confirmed the stability of the enzyme machinery. The analysis also showed the involvement of residue R73 in solvent exchange events and suggested that it does not serve as a channel for GSH entry into the endoplasmic reticulum membrane.

MOLECULAR INFORMATICS (2022)

Article Chemistry, Medicinal

Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2

Simone Di Micco, Rahila Rahimova, Marina Sala, Maria C. Scala, Giovanni Vivenzio, Simona Musella, Graciela Andrei, Kim Remans, Lea Mammri, Robert Snoeck, Giuseppe Bifulco, Francesca Di Matteo, Vincenzo Vestuto, Pietro Campiglia, Jose A. Marquez, Alessio Fasano

Summary: Despite the effectiveness of vaccines in mitigating the spread of SARS-CoV-2, therapeutics offer additional benefits in controlling viral transmission. This study developed tripeptide derivatives targeting SARS-CoV-2 Mpro and identified compound 58 as a promising candidate with improved antiviral activity against variants and safety in vitro and in vivo. These findings suggest the potential of compound 58 for intranasal administration.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 binders

Ester Colarusso, Sara Ceccacci, Maria Chiara Monti, Erica Gazzillo, Assunta Giordano, Maria Giovanna Chini, Maria Grazia Ferraro, Marialuisa Piccolo, Dafne Ruggiero, Carlo Irace, Stefania Terracciano, Ines Bruno, Giuseppe Bifulco, Gianluigi Lauro

Summary: Targeting bromodomain-containing protein 9 (BRD9), a set of 2,4,5-trisubstituted-2,4-dihydro-3H- 1,2,4-triazol-3-one-based compounds was investigated for the development of new anticancer agents. Through in silico studies, chemical synthesis, biophysical and biological evaluation, compounds with promising selectivity and binding affinity for BRD9 were identified. The multidisciplinary approach used in this study accelerated the selection process and provided insights for the synthesis of novel BRD9 binders.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

In Silico Identification and In Vitro Evaluation of New ABCG2 Transporter Inhibitors as Potential Anticancer Agents

Simone Di Micco, Veronica Di Sarno, Martina Rossi, Vincenzo Vestuto, Takumi Konno, Sara Novi, Mario Felice Tecce, Valeria Napolitano, Tania Ciaglia, Andrea Vitale, Isabel Maria Gomez-Monterrey, Giuseppe Bifulco, Alessia Bertamino, Carmine Ostacolo, Paolo Blasi, Alessio Fasano, Pietro Campiglia, Simona Musella

Summary: Different mechanisms contribute to cancer multidrug resistance, including increased drug efflux, enhanced cellular repair mechanisms, and alterations of drug metabolism or targets. ABCG2, a transporter protein, promotes drug efflux and causes chemotherapeutic resistance in malignant cells. Through a multidisciplinary approach, a new selective inhibitor (8) of ABCG2 has been identified, which effectively improves the cytotoxicity of mitoxantrone in hepatocellular carcinoma and transfected breast cancer cell lines. This inhibitor also demonstrates its efficacy in reversing multidrug resistance with the overexpression of the ABCG2 pump.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: In Vitro and In Vivo Anti-Inflammatory Characterization

Ida Cerqua, Simona Musella, Lukas Klaus Peltner, Danilo D'Avino, Veronica Di Sarno, Elisabetta Granato, Vincenzo Vestuto, Rita Di Matteo, Simona Pace, Tania Ciaglia, Rossella Bilancia, Gerardina Smaldone, Francesca Di Matteo, Simone Di Micco, Giuseppe Bifulco, Giacomo Pepe, Manuela Giovanna Basilicata, Manuela Rodriquez, Isabel M. Gomez-Monterrey, Pietro Campiglia, Carmine Ostacolo, Fiorentina Roviezzo, Oliver Werz, Antonietta Rossi, Alessia Bertamino

Summary: The identification of an indoline-based compound that inhibits both 5-lipoxygenase and soluble epoxide hydrolase has opened up new possibilities for the rational design of multitarget drugs in medicinal chemistry. This compound showed promising activity in both enzymatic and cellular assays, and exhibited remarkable anti-inflammatory efficacy in vivo. Further investigation is needed to explore the potential use of this compound as an anti-inflammatory agent.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Identification of 2-Aminoacyl-1,3,4-thiadiazoles as Prostaglandin E2 and Leukotriene Biosynthesis Inhibitors

Marianna Potenza, Assunta Giordano, Maria G. Chini, Anella Saviano, Christian Kretzer, Federica Raucci, Marina Russo, Gianluigi Lauro, Stefania Terracciano, Ines Bruno, Maria Iorizzi, Robert K. Hofstetter, Simona Pace, Francesco Maione, Oliver Werz, Giuseppe Bifulco

Summary: A multi-step scientific workflow led to the discovery of a novel class of PGE(2)/leukotriene biosynthesis inhibitors with in vivo activity. Four new compounds showed strong anti-inflammatory properties in vitro and demonstrated prominent anti-inflammatory activity in a mouse model.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Article Chemistry, Medicinal

Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis

Simona Musella, Danilo D'Avino, Lukas Klaus Peltner, Veronica Di Sarno, Ida Cerqua, Fabrizio Merciai, Vincenzo Vestuto, Tania Ciaglia, Gerardina Smaldone, Francesca Di Matteo, Simone Di Micco, Valeria Napolitano, Giuseppe Bifulco, Giacomo Pepe, Eduardo Maria Sommella, Manuela Giovanna Basilicata, Giovanna Aquino, Isabel M. M. Gomez-Monterrey, Pietro Campiglia, Carmine Ostacolo, Fiorentina Roviezzo, Oliver Werz, Antonietta Rossi, Alessia Bertamino

Summary: This study describes the rational development of soluble epoxide hydrolase (sEH) inhibitors for the treatment of acute pancreatitis (AP). The most promising compound, 28, was identified through in vitro screening and molecular modeling studies. Compound 28 demonstrated remarkable efficacy in reducing inflammatory damage in a mouse model of cerulein-induced AP. Metabololipidomic analysis further confirmed the molecular mechanism of sEH inhibition in the anti-AP activity of compound 28. Overall, compound 28 shows strong effectiveness as an sEH inhibitor with potential for pharmacological treatment of AP.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Identification of 2-Aminoacyl-1,3,4-thiadiazoles as Prostaglandin E2 and Leukotriene Biosynthesis Inhibitors

Marianna Potenza, Assunta Giordano, Maria G. Chini, Anella Saviano, Christian Kretzer, Federica Raucci, Marina Russo, Gianluigi Lauro, Stefania Terracciano, Ines Bruno, Maria Iorizzi, Robert K. Hofstetter, Simona Pace, Francesco Maione, Oliver Werz, Giuseppe Bifulco

Summary: The application of a multi-step scientific workflow led to the discovery of a new class of PGE2/leukotriene biosynthesis inhibitors with in vivo activity. Through screening a virtual library of approximately 4.2 x 105 molecules, a small set of compounds were identified and synthesized, which showed strong anti-inflammatory properties in vitro and in vivo. Specifically, four novel derivatives exhibited significant inhibition of PGE2 biosynthesis and interfered with leukotriene biosynthesis in cell-based systems. Furthermore, the most promising compound displayed prominent in vivo anti-inflammatory activity in a mouse model.

ACS MEDICINAL CHEMISTRY LETTERS (2023)

暂无数据